Jia-Shiong Chen

Title: Innovations of Jia-Shiong Chen in Tumor Microenvironment Research

Introduction

Jia-Shiong Chen is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of compounds that target tumor microenvironments. With a total of four patents to his name, Chen's work focuses on innovative approaches to cancer treatment.

Latest Patents

Chen's latest patents include groundbreaking research on histone deacetylase inhibitors for immunomodulation in tumor microenvironments. This patent discusses compounds that are class I HDAC inhibitors, which possess epigenetic immunomodulatory activities that inhibit the growth of tumor cells. Another notable patent is the anticancer combination of chidamide and celecoxib salts. This invention relates to a combination of a histone deacetylase (HDAC) inhibitor, chidamide in an acidic salt form, and a nonsteroidal anti-inflammatory drug (NSAID), celecoxib in a basic salt form. This combination significantly regulates the tumor microenvironment and dramatically improves anti-cancer activity.

Career Highlights

Jia-Shiong Chen is associated with Great Novel Therapeutics Biotech & Medicals Corporation, where he continues to advance his research and innovations. His work has been pivotal in exploring new therapeutic avenues for cancer treatment.

Collaborations

Some of his notable coworkers include Ye-Su Chao and Chia-Nan Chen, who collaborate with him on various research projects aimed at enhancing cancer therapies.

Conclusion

Jia-Shiong Chen's contributions to the field of biotechnology and cancer treatment through his innovative patents highlight his role as a leading inventor. His research continues to pave the way for new therapeutic strategies in combating cancer.